Systematic integration of biomedical knowledge prioritizes drugs for repurposing

Abstract : The ability to computationally predict whether a compound treats a disease would improve the economy and success rate of drug approval. This study describes Project Rephetio to systematically model drug efficacy based on 755 existing treatments. First, we constructed Hetionet (neo4j.het.io), an integrative network encoding knowledge from millions of biomedical studies. Hetionet v1.0 consists of 47,031 nodes of 11 types and 2,250,197 relationships of 24 types. Data were integrated from 29 public resources to connect compounds, diseases, genes, anatomies, pathways, biological processes, molecular functions, cellular components, pharmacologic classes, side effects, and symptoms. Next, we identified network patterns that distinguish treatments from non-treatments. Then, we predicted the probability of treatment for 209,168 compound-disease pairs (het.io/repurpose). Our predictions validated on two external sets of treatment and provided pharmacological insights on epilepsy, suggesting they will help prioritize drug repurposing candidates. This study was entirely open and received realtime feedback from 40 community members.
Document type :
Journal articles
Complete list of metadatas

Cited literature [244 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02154787
Contributor : Ana Paula Dutra Azevedo <>
Submitted on : Thursday, June 13, 2019 - 8:27:44 AM
Last modification on : Wednesday, August 7, 2019 - 12:16:02 PM

File

elife-26726.pdf
Publisher files allowed on an open archive

Identifiers

  • HAL Id : inserm-02154787, version 1

Collections

Citation

Daniel Himmelstein, Antoine Lizee, Christine Hessler, Leo Brueggeman, Sabrina Chen, et al.. Systematic integration of biomedical knowledge prioritizes drugs for repurposing. eLife, eLife Sciences Publication, 2017. ⟨inserm-02154787⟩

Share

Metrics

Record views

39

Files downloads

76